189 related articles for article (PubMed ID: 17973848)
21. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
23. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
[TBL] [Abstract][Full Text] [Related]
26. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
[TBL] [Abstract][Full Text] [Related]
27. A novel panel of blood markers to assess the degree of liver fibrosis.
Calès P; Oberti F; Michalak S; Hubert-Fouchard I; Rousselet MC; Konaté A; Gallois Y; Ternisien C; Chevailler A; Lunel F
Hepatology; 2005 Dec; 42(6):1373-81. PubMed ID: 16317693
[TBL] [Abstract][Full Text] [Related]
28. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
Poynard T; Munteanu M; Deckmyn O; Ngo Y; Drane F; Castille JM; Housset C; Ratziu V; Imbert-Bismut F
J Hepatol; 2012 Sep; 57(3):541-8. PubMed ID: 22612998
[TBL] [Abstract][Full Text] [Related]
29. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
[TBL] [Abstract][Full Text] [Related]
30. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
[TBL] [Abstract][Full Text] [Related]
31. Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C.
Canbakan M; Senturk H; Canbakan B; Toptas T; Tabak O; Ozaras R; Tabak F; Balcı H; Sut N; Ozbay G
Nephron Clin Pract; 2011; 117(3):c289-95. PubMed ID: 20847572
[TBL] [Abstract][Full Text] [Related]
32. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
Halfon P; Munteanu M; Poynard T
Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
[TBL] [Abstract][Full Text] [Related]
33. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
[TBL] [Abstract][Full Text] [Related]
35. [Non-invasive detection of liver fibrosis in patients with chronic hepatitis C].
Aiglová K; Ehrmann J; Ehrmann J
Cas Lek Cesk; 2007; 146(6):542-5. PubMed ID: 17650594
[TBL] [Abstract][Full Text] [Related]
36. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
[TBL] [Abstract][Full Text] [Related]
37. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
Fabris C; Smirne C; Toniutto P; Colletta C; Rapetti R; Minisini R; Falleti E; Pirisi M
Clin Biochem; 2006 Apr; 39(4):339-43. PubMed ID: 16487951
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
[TBL] [Abstract][Full Text] [Related]
39. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
